A global initiative, addressing the global disparity in effective pain relief medication access, especially in low- and middle-income countries.
When we started working globally in 2020, we realised just how many patients are not receiving effective pain relief medication. Patients in low- and middle-income countries do not always have the financial means to buy medicines to relieve pain and they are sometimes dying in extreme pain. This is not necessary and can be changed.
We can do better!
One of our patient advocates is an experienced anaesthesiologist. He treats cancer patients suffering from pain, especially that which is caused by inflammation, using a well-known, safe, cheap and effective medicine i.e., Lidocaine, that can easily be used all over the globe.
In addition to its painkilling qualities, Lidocaine also decreases inflammation which can be the cause of pain, not only in cancer, but also in sickle cell disease for example. 50% of the cancers are, according to our ambassador and Nobel Prize winner, the late professor Zur Hausen, caused by inflammation
